A Decade Strong — Celebrating 10 Years of BMWS
A Decade Strong — Celebrating 10 Years of BMWS
Cellares is creating the future of cell therapy manufacturing and accelerating access to life-saving cell therapies. The company is developing a one-of-a-kind solution to overcome the limitations associated with manufacturing cell therapies that are more affordable and widely available to patients in need. With Cellares’ proprietary platform—the Cell Shuttle—biopharma companies, academic research centers, and CDMOs will no longer have to compromise by either choosing a manufacturing platform that is semi-automated but lacks workflow flexibility, or one that provides customization but not the end-to-end automation needed to manufacture at scale. The company is headquartered in South San Francisco, Calif.
Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® technology platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis™ manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis’ unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications.
FUJIFILM Diosynth Biotechnologies is an industry-leading cGMP Contract Development and Manufacturing Organization (CDMO) supporting the biopharmaceutical industry in the development and production of biologics, vaccines and advanced therapies. Our focus is to combine technical leadership in process development and cGMP manufacturing supported by a strong team of over 4,000 employees and a reputation for excellent customer service. We are a trusted partner of many clients, from early stage biotechs to large pharma.
IDBS provides cloud-based solutions to meet the unique data management challenges faced by Life Sciences teams throughout the product and process lifecycle and across the supply chain. Our innovative Polar platform is the industry’s first digital data backbone enabling customers in research, development and manufacturing to efficiently and compliantly access critical data and insights to make faster, smarter decisions with greater confidence.
IDBS serves thousands of users across hundreds of organizations around the globe, including 23 of the top 25 pharmaceutical companies and more than 250 small and medium-sized pharma and biopharma companies, CROs, CDMOs, and CMOs.
Just – Evotec Biologics, wholly owned by Evotec SE, is a CDMO offering development and manufacturing services for antibody, next-generation biologics, and biosimilar products. We collaborate with partners starting from antibody discovery through process development and manufacturing with sites in US and Europe. We designed our technologies to reduce cost of goods and help expand global access to affordable high-quality biotherapeutics. Our team combines deep industry experience in the fields of data, protein, process, and manufacturing sciences including automation with highly integrated and flexible capabilities to break through the scientific and economic barriers associated with the development of protein therapeutics.
MasterControl Inc. provides cloud-based software to empower manufacturers in life sciences and other regulated industries to digitize and streamline their processes to reduce errors on the shop floor. Our mission is to help our customers bring life-changing products to more people sooner.
Manufacturing Excellence is a modern MES designed to simplify manufacturing execution for manufacturers of all sizes. It delivers proven results in the metrics that matter – from faster review and release, more throughput, and fewer human errors. Learn how to take a smarter approach to manufacturing at mastercontrol.com.
Project Farma is an industry leader in providing project management, validation, engineering and consulting services with a proven track record in gene and cell therapy. We partner with gene and cell therapy organizations in addition to healthcare, pharmaceutical, bio-pharmaceutical companies to support finding ground-breaking treatments and solutions. Our gene and cell therapy clients include early stage startups, establish cell and gene therapy companies and CMOs / CROs. We are committed to helping advance cutting-edge medicines by leveraging our deep knowledge and broad experience in cell and gene therapy to meet any new challenges.
Vision. Expertise. Success.
AbbVie Contract Manufacturing partners with companies across the globe to develop, scale and manufacture pharmaceutical products and bring them successfully to market.
Drawing on more than four decades of success as the manufacturing division of AbbVie, we have the depth of experience and the technical knowledge to navigate issues and deliver the innovative solutions customers need. We are much more than a CMO – we are your partner for success.
Compliance Architects LLC delivers high-value compliance, quality, and regulatory consulting services to companies directly regulated by the U.S. FDA and other global regulatory authorities. With capabilities ranging from quality systems implementations to audits, inspection readiness, enforcement remediation, and outsourced compliance services, Compliance Architects LLC has the experience, expertise, and delivery capability to significantly improve your company’s business outcomes. Jack Garvey is CA’s founder and CEO, a chemical engineer and a practicing regulatory attorney, and has spent his entire career helping companies navigate the challenges at the intersections of science, engineering, business, and law.
DCI, Inc., founded in 1955 with its corporate offices in Saint Cloud, MN, is a world leading manufacturer of stainless-steel storage and processing vessels, agitators, and fully integrated, skidded systems for the hygienic industries, particularly pharmaceutical, biopharmaceutical, biotech, animal health and cosmetic industries. Vertically fully integrated, DCI’s portfolio of products and services includes tanks, pressure vessels, and skidded processing equipment with aseptic media, batch and mixing tanks, fermenters, bioreactors, horizontal and vertical storage tanks. In addition to our standard equipment, DCI also custom-engineers and fabricates skidded systems to fit your company needs and certifies your equipment to meet all your regulatory requirements. For more information, please visit www.dciinc.com.
In April 2019, Emerson acquired Bioproduction Group (Bio-G), a leader in simulation, modeling, and scheduling software for biomanufacturing. Bio-G’s scheduling and modeling systems combined with Emerson’s extensive life sciences technology and expertise portfolio will help companies bring therapies for cancer, diabetes, and other illnesses to patients sooner.
Life sciences companies continually look to accelerate the production of patient therapies and the Bio-G Scheduling software helps them accurately predict future plant resource availability to optimize manufacturing production. The scheduling software delivers an instantaneous view, accessible across an organization, into the current and future state of the plant, providing decision support to help increase facility uptime and reduce schedule-related product losses.
Resilience is a technology-focused manufacturing company dedicated to broadening access to complex medicines. Founded in 2020, the company aims to build a sustainable network of high-tech, end-to-end manufacturing solutions to ensure the medicines of today and tomorrow can be made quickly, safely and at scale. By continuously advancing the science of biopharmaceutical manufacturing and development, Resilience seeks to free its partners to focus on the discoveries that improve patients’ lives.
Samsung Biologics is a fully integrated, end-to-end CDMO service provider, offering seamless development and manufacturing solutions from cell line development to final aseptic fill/finish, as well as laboratory testing support for the biopharmaceutical products we manufacture. Our state-of-the-art facilities are cGMP compliant with bioreactors ranging from small to large scales to serve varying client needs.
To maximize our operational efficiency and expand our capabilities in response to growing biomanufacturing demands, Samsung Biologics completed Bio Campus I with Plant 4 offering a combined 604KL total capacity, and launched Bio Campus II with the construction of Plant 5, which will be operational in April 2025 adding 184KL biomanufacturing capacity.
Digital CHANGE to Future-Proof BIOMANUFACTURING
Zaether is a leading provider of digital enablement services focused on optimizing biomanufacturing through cutting-edge IT/OT integration. With deep expertise in transforming complex operational environments, Zaether partners with global leaders to streamline processes, reduce time-to-market, and drive innovation in biomanufacturing. By offering tailored digital solutions, Zaether enables biopharma companies to enhance production efficiency, ensure compliance, and maintain competitiveness in a rapidly evolving industry.
Russell Reynolds Associates is a global search and leadership advisory firm. Our 425+ consultants in 46 offices work with public, private and nonprofit organizations across all industries and regions. We help our clients build teams of transformational leaders who can meet today’s challenges and anticipate the digital, economic and political trends that are reshaping the global business environment. From helping boards with their structure, culture and effectiveness to identifying, assessing and defining the best leadership for organizations – our teams bring their decades of expertise to help clients solve their most complex leadership issues.
Altruist Biologics is a fully integrated CDMO, focusing on the development and commercial manufacturing of antibodies, fusion proteins, ADCs, and other drugs. From cell line development to aseptic fill/finish, we support our clients in producing affordable, high-quality biopharmaceuticals for the benefit of patients worldwide.
We offer a total 60KL capacity at our Suzhou site, meeting the GMP requirements of the FDA, EMA, and NMPA, and commenced partial operations at our new Hangzhou facility with the completion of four 20KL bioreactors, the first and largest of its kind in China. The site will hold a total capacity of 172KL when it becomes fully completed in 2025.
Altruist offers an end-to-end solution that includes:
Building on our accumulated expertise and advanced technologies, we continuously strengthen our capabilities and quality systems in line with anticipated market needs, providing flexible, cost-effective services while accelerating your path to patients.
Apprentice developed the first AI-powered cloud platform built to accelerate batch-based manufacturing – the Tempo Manufacturing Cloud. Tempo provides seamless processing through every layer of your manufacturing ecosystem in one platform by combining historically distributed systems — Manufacturing Execution System (MES), Distributed Control System (DCS), Laboratory Execution System (LES), eLogs, Work Instructions — giving you comprehensive visibility and control across every team, site, and external partner. Tempo delivers a modern and easy-to-use experience across web, mobile, and wearable devices that’s rapidly adopted across all operational levels. To learn more about Apprentice, visit www.apprentice.io.
Asimov’s mission is to advance humanity’s ability to design living systems, enabling biotechnologies with outsized societal benefit. The company is developing a synthetic biology platform – from cells to software – to design and manufacture next-generation therapeutics, including cell & gene therapies, through a combination of products, services, & collaborations. Founded by bioengineers from MIT and Boston University and headquartered in Boston, the company has raised over $200 million to date.
Aurigene Pharmaceutical Services is a leading contract research, development, and manufacturing organization (CDMO). Built on the legacy of accelerating innovation and backed by a vast experience in drug discovery and development our mission is to relentlessly work for the success of our clients and to build long term relationships through a holistic approach to accelerate the journey of a molecule from laboratory to market. By providing access to our resources, knowledge and experience, we create success for our clients and ultimately patients. We offer integrated and standalone services for medicinal chemistry, biology, preclinical services, DMPK studies, development and manufacturing for clinical phase I-III programs, regulatory submission batches, and commercial manufacturing. A differentiating factor is the integrated API and formulations service that spans from key starting material, advanced intermediates, APIs to finished products such as oral solids, sterile products, nasal solutions etc. Our development services in India are complemented by cGMP commercial manufacturing facilities in the UK, Mexico, USA and India.
Avid Bioservices (NASDAQ:CDMO), an S&P SmallCap 600 company, is a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP manufacturing of biologics. The company provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. With 30 years of experience producing monoclonal antibodies and recombinant proteins, Avid’s services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. For early-stage programs the company provides a variety of process development activities, including upstream and downstream development and optimization, analytical methods development, testing and characterization. The scope of our services ranges from standalone process development projects to full development and manufacturing programs through commercialization.
Leading the Life Sciences in asset management for 30+ years, Blue Mountain® has a unique position in the industry backed by a proven legacy. Founded in 1989, Blue Mountain offers a complete, integrated solution, helping hundreds of Pharmaceutical, Biotech, Cell and Gene Therapy, Medical Device, and Contract Manufacturing companies. From set-up to installation and from training to validation , our company helps life sciences companies master GMP asset management by implementing our best-in-class software – enabling them to leverage the cloud, drive paperless processes, and ensure regulatory compliance.
Blue Mountain’s ultimate goal is to help regulated companies introduce a new, safe, and effective therapy to market. Getting there involves sophisticated processes and products that must meet the highest standards.
Boehringer Ingelheim is a leading research-driven biopharmaceutical company and creates value through innovation in areas of high unmet medical need.
As one of the world’s largest manufacturers for biopharmaceuticals with in-depth experience in this field, the company is an industry pioneer and collaborates with top 20 pharma companies and innovative biotechs.
Boehringer Ingelheim BioXcellence™ reliably supplies innovative therapies that transform lives, today and for generations to come. We create solutions with our partners, building on our can-do attitude to improve patient health.
Our business is empowered by 5,000 dedicated and well-trained employees in development, quality and manufacturing and has access to a global manufacturing network providing the entire production chain from DNA to Fill & Finish. Our track records, both in commercial and clinical supply speak for themselves – since we started offering contract manufacturing in 1995, we have successfully brought 40 biologics to the market and have transferred and optimized more than 150 development and manufacturing projects at all stages from our customers to our facilities, as well as within our network.
While collaborating with our partners we never lose sight of the patients that depend on biopharmaceutical therapies. We offer capabilities to complement your expertise, so together we can deliver better therapies.
At CAI, we are a professional services firm designed to accelerate operational readiness and excellence in critical environments. Our team of engineering, quality, and operations experts combines top-tier talent with the latest technology to deliver projects on time and within budget. We’re committed to continuous improvement, real connections, and the highest standards, aiming to lead the industry and build the future. Are you ready?
The world leader in clean air technology and air filter production, Camfil is the foremost supplier of air filtration, terminal and containment housings to the Life Science industries.
We provide the tools to achieve sustainability, maintain high air quality and reduce airborne contaminants, while lowering total cost of ownership.
Excellos is your cell therapy CDMO, from starting material to commercialization. We provide custom GMP services to develop and manufacture cell therapies. Our deeply characterized cells help reduce variabilities in clinical responses and increase your probability of success. Current applications supported focus on TIL-based therapies, autologous and allogenic CAR-T/NK therapies and TCR therapies. Our customized services include donor recruitment, cell isolation, transduction, expansion and scale up GMP production. Excellos delivers the promise of cell potency.
Hexagon is the global leader in digital reality solutions, combining sensor, software and autonomous technologies. We are putting data to work to boost efficiency, productivity, quality and safety across industrial, manufacturing, infrastructure, public sector, and mobility applications.
Our technologies are shaping production and people-related ecosystems to become increasingly connected and autonomous – ensuring a scalable, sustainable future.
Hexagon’s Asset Lifecycle Intelligence division helps clients design, construct, and operate more profitable, safe, and sustainable industrial facilities. We empower customers to unlock data, accelerate industrial project modernization and digital maturity, increase productivity, and move the sustainability needle.
Our technologies help produce actionable insights that enable better decision-making and intelligence across the asset lifecycle of industrial projects, leading to improvements in safety, quality, efficiency, and productivity, which contribute to Economic and Environmental Sustainability.
Hexagon (Nasdaq Stockholm: HEXA B) has approximately 24,500 employees in 50 countries and net sales of approximately 5.5bn USD. Learn more at hexagon.com and follow us @HexagonAB.
INCOG BioPharma Services is designed and built based on decades of experience with a clear purpose: to be a customer-driven CDMO providing a new standard of excellence for injectable drug products.
The company’s service offering includes filling drug products into vials, syringes, and cartridges. INCOG BioPharma also offers support services, including analytical development, stability testing and storage, final inspection, labeling, packaging, and device assembly.
We go above and beyond to understand your requirements, meet your needs, and foster a collaborative partnership. Experience better and discover the INCOG way.
Körber Pharma Software, formerly Werum IT Solutions, is the world’s leading supplier of manufacturing execution systems (MES) and manufacturing IT solutions for the pharmaceutical and biopharmaceutical industries. Our out-of-the-box PAS-X software is run by the majority of the worlds to 30 pharmaceutical and biotech companies and by many mid-sized manufacturers.
Our software product, Werum PAS-X MES, is recognized as the world’s leading Manufacturing Execution System (MES) for the pharma, biotech and cell & gene therapy industries. We offer a full-scope MES solution comprising the PAS-X software product and pre-configured content for pharmaceutical, biotech and cell & gene processes completed by consulting, training and support services.
Körber is an international technology group with about 13,000 employees, more than 100 locations worldwide and a common goal: We turn entrepreneurial thinking into customer success and shape the technological change. At the Körber Pharma we are delivering the difference along the pharma value chain with our unique portfolio of integrated solutions.
L7 Informatics reimagines data intelligence for modern life sciences and healthcare organizations. Beyond simple data management, L7 provides tools that optimize the flow of information between process and people, unlocking innovation at every stage of the clinical, research, and manufacturing value chains. Our comprehensive operating environment and software stack bring flexible, secure, and collaborative data intelligence to your entire operation. From regulatory compliance and workflow orchestration to customized applications and integrations, our end-to-end transformation engine helps organizations solve today’s challenges and realize tomorrow’s opportunities. L7|ESP™ is designed to unlock innovation at every stage of the clinical, research, and manufacturing value chain. From data and workflow orchestration to custom apps and integrations, L7|ESP is an end-to-end transformation engine to help solve today’s challenges and realize tomorrow’s opportunities.
The L7 Manufacturing Execution System (MES) offers a unified platform approach to manufacturing operations management. While traditional MES is rigid and siloed from other systems and equipment, leaving operations still relying on forms and spreadsheets, L7 MES provides a holistic manufacturing operations management experience. Additionally, the L7 MES system is designed for developing and progressing seamlessly to CGMP production. We are CGMP-ready and provide the flexibility to support the early-stage process development, capturing and curating your data resource across your journey to clinical and commercial production.
LOTTE BIOLOGICS was established in 2022 and is headquartered in Seoul, South Korea. Utilizing a two-track strategy of acquiring and building, LOTTE BIOLOGICS is solidifying its competitiveness in the CDMO market. Currently, the company has a facility for biopharmaceutical antibody production in the Syracuse region of the United States and is in the process of constructing a 360,000L bio campus in the Songdo area of Incheon, South Korea.
Northway Biotech is an end-to-end biologics contract development and manufacturing organization (CDMO) supporting customers worldwide. The company’s wide-ranging expertise and vertically integrated service offering translate to the ability to rapidly execute multiple projects from its state-of-the-art GMP facilities while ensuring full process and product compliance at all stages of research, development and commercial manufacturing. Northway Biotech is a privately owned company founded in 2004 and located in Vilnius, Lithuania and Waltham, Mass., U.S.
ParkourSC delivers agility and transparency in supply chain operations for pharmaceutical, life sciences, and biologics companies, to drive strategic innovation and resilience, enable timely decisions, narrow demand and supply variances, and increase revenue.
Our digital supply chain operations platform improves patient outcomes by ensuring compliance, quality, and timely delivery of sensitive therapies. The platform provides a “command center” to predict at-risk situations in the supply chain by monitoring the performance of every entity, flagging quality and compliance risks, automating workflows across organizations, fostering collaboration to resolve issues and prevent waste, and to bridge the gap in planning and execution cycles by automatically delivering real-time updates to planners.
PathoQuest is a global CRO that specializes in biologics quality testing based on next-generation sequencing (NGS) for viral safety and genetic characterization. The company’s proprietary NGS-based testing approach delivers actionable Quality Control reports to the biopharmaceutical industry for cell & gene therapy, vaccines and recombinants.
With a proven track record, PathoQuest offers a team of 50 genomic experts over two sites in France (Paris) and the U.S. (Wayne, PA). Our expert team is readily available to support rapid and robust Quality Control (QC) testing at GMP and non-GMP levels.
PathoQuest is at the forefront of providing NGS-based testing solutions that can expedite the commercial availability of biologics and have the potential to replace current standardized in vivo and in vitro testing options.
Biologics Quality Testing
Faster, Safer, Animal Free.
For more information, visit www.pathoquest.com or contact us at contact@pathoquest.com.
For the past 20+ years, ProPharma has improved the health and wellness of patients by providing advice and expertise that empowers biotech, med device, and pharmaceutical organizations of all sizes to confidently advance scientific breakthroughs and introduce new therapies. As the world’s largest RCO (Research Consulting Organization), ProPharma partners with its clients through an advise-build-operate model across the complete product lifecycle. With deep domain expertise in regulatory sciences, clinical research solutions, quality & compliance, pharmacovigilance, medical information, and R&D technology, ProPharma offers an end-to-end suite of fully customizable consulting solutions that de-risk and accelerate our partners’ most high-profile drug and device programs.
We are a biotech small business focused on developing customized single-domain antibodies for pharmaceutical applications. We can screen our synthetic library in less than a month and provide novel antibodies to a desired target starting at $10,000.
Separation, Enrichment, Purification. Engineers and scientists come to Rousselet-Robatel when they want robust, performance-based separation & recovery solutions. From kilogram capacities on the R&D laboratory bench up to production demands exceeding metric tons per day, the bio-pharmaceutical range of cGMP centrifuges from Rousselet-Robatel are used in applications requiring solid-liquid phase separation, liquid-liquid extraction and enrichment, and chromatographic purification.
At Selkirk, our goal is to become your most reliable partner for aseptic Fill/Finish services. In our new state-of-the-art facility, we provide high yield manufacturing of your critical products to meet patients’ needs. Our facility is purpose-built for contract manufacturing with unidirectional process flows, advanced SKAN isolators and high yield Bausch & Stroebel filling equipment. Vial capacity currently available.
APC helps biopharma companies slash drug development times by delivering breakthrough science at lightning-fast process development speed. We thrive on radical collaboration – challenging ourselves and our clients to deliver for patients faster.
iAchieve, our proprietary, cloud-based knowledge management platform digitizes every aspect of your medicine’s journey from process definition through process characterization and into the manufacturing facility that best suits your needs.
Wacker Biotech is your all-in-one CDMO partner of choice for the production of advanced nucleic acid therapeutics and vaccines, as well as recombinant proteins and live biotherapeutic products (LBP) based on microbial systems. We offer mRNA production across the full manufacturing chain, from plasmid DNA (pDNA) to mRNA to LNP formulation, for vaccines and advanced gene therapies. Offerings include diverse solutions ranging from pDNA supply using our PLASMITEC® platform, to process development, transfer of mRNA-based processes, and GMP manufacturing for clinical and commercial supply. Additionally, customers benefit from a broad spectrum of LNP formulations for their mRNA-based product.
In June 2024, we completed construction and opened a state-of-the-art mRNA competence center in Halle, Germany, greatly expanding our mRNA production capacity. This complements existing capabilities at our global GMP facilities in Amsterdam, Halle and San Diego. Also complementing these sites is a dedicated R&D center in Munich, Germany with scientific experts leading innovations in pDNA manufacturing, mRNA production, LNP formulation, and analytical development.
Wacker Biotech is a wholly owned subsidiary of 110-year-old Wacker Chemie AG. For more information, visit: wacker.com/biologics.
Whatfix, a Digital Adoption Platform, works with leading Pharmaceutical and Life Sciences companies in the US including Grifols, Sanofi, J&J, Merck, and Ferring Pharmaceuticals, to drive their digital transformation journey and business outcomes. Its in-app guidance and just-in-time support assists users to perform complex, critical tasks on applications such as Laboratory Information Management Systems (LIMS), Regulatory Information Management (RIM) systems, Quality Management Systems (QMS), Clinical Trial Management Systems (CTMS), and more. This helps keep employees up-to-date with quality policies, increase speed-to-market of drugs, and improve patient and worker safety.Whatfix, a Digital Adoption Platform, works with leading Pharmaceutical and Life Sciences companies in the US including Grifols, Sanofi, J&J, Merck, and Ferring Pharmaceuticals, to drive their digital transformation journey and business outcomes. Its in-app guidance and just-in-time support assists users to perform complex, critical tasks on applications such as Laboratory Information Management Systems (LIMS), Regulatory Information Management (RIM) systems, Quality Management Systems (QMS), Clinical Trial Management Systems (CTMS), and more. This helps keep employees up-to-date with quality policies, increase speed-to-market of drugs, and improve patient and worker safety.
Accenture is a leading global professional services company, providing a broad range of services and solutions in strategy, consulting, digital, technology and operations. Combining unmatched experience and specialized skills across more than 40 industries and all business functions—underpinned by the world’s largest delivery network—Accenture works at the intersection of business and technology to help clients improve their performance and create sustainable value for their stakeholders. With 482,000 people serving clients in more than 120 countries, Accenture drives innovation to improve the way the world works and lives.
Bayer has been developing and manufacturing biopharmaceuticals for more than 30 years, including some of the most complex biologics on the market. Our expertise includes the development of innovative manufacturing platforms to bring products to the clinic and commercial markets across a variety of modalities, including recombinant proteins and cell therapies. An innovator in biologics manufacturing, Bayer is investing significantly in new infrastructure including cell therapy development laboratories and our first cell therapy launch facility opened in 2023 (late-stage clinical and commercial manufacturing capacity).
We know what it takes to bring products to patients with accelerated development concepts that build in quality-by-design at every step and CMC strategies that meet the expectations of health authorities around the world. We are a global organization with a proven record of winning collaborations and internal programs that progress through development and manufacturing across different sites, and we bring strong technology-transfer expertise to your product candidates.
C&F is a global technology firm specializing in scalable, custom M&SC innovations. For over 20 years, we’ve delivered best-in-class, award-winning solutions to regulated enterprises, providing measurable improvements to global operations. We’ve enabled clients to improve cost and cycle time KPIs through the deployment of custom solutions, tailored to unique challenges. Our teams include strategic partners with broad business insights and delivery SMEs with deep technical expertise, providing agile services and solutions that guide organizations through their digital maturity journey. Our specialized services encompass digital transformation consulting, cutting-edge enterprise data lakes, digital products, data analytics, and AI capabilities. With a proven track record of delivering large scale transformations for Fortune 500 companies, C&F brings the best of two worlds: the operational excellence, scalability, and value of a large firm, combined with the flexibility of a startup. Together, we find the way!
Cytiva is a global provider of technologies and services that help advance and accelerate the development and manufacture of therapeutics. Previously GE Healthcare Life Sciences, Cytiva’s diverse portfolio includes well-recognized brands such as ÄKTA, Amersham, Biacore, FlexFactory, HyClone, MabSelect, Whatman and Xcellerex. Cytiva brings speed, efficiency and capacity to research and manufacturing workflows, enabling the delivery of transformative medicines to patients.
EwingCole/EC Build is a fully integrated Architecture, Engineering, and Construction conglomerate specializing in the design and delivery of advanced therapies, biological manufacturing and laboratory facilities. Our unique emphasis on Cell & Gene Therapy facilities has helped many companies move from manufacturing strategy, master planning, and concept design to full-scale commercial production.
Our staff of over 400 architects, process engineers, MEP and structural engineers, planners and interior designers leverage their broad design and delivery expertise to provide our clients with the most available, appropriate and affordable solutions to meet their needs.
Honeywell Life Sciences, the makers of TrackWise, are on a mission to accelerate innovation for a healthier future. From manufacturing life-saving drugs to safeguarding supply chain continuity, Life Sciences organizations partner with Honeywell to solve their most critical challenges and drive meaningful patient and business outcomes. Honeywell empower Life Science companies with the latest innovation to improve operational efficiency and bring safer products to market faster, by automating and optimizing their manufacturing and supply chain eco-system. Life Sciences companies worldwide trust Honeywell for the advanced technology solutions and domain expertise they need to drive continuous business improvements while helping them make smarter faster decisions about the things that matter most.
IDA Ireland was founded in 1949 as the Irish Government agency responsible for the attraction and retention of foreign direct investment (FDI) into Ireland. IDA Ireland partners with multinational companies to attract investment, providing jobs for the economic and social benefit of Ireland.
We have partnered with 1,200 companies to establish operations in Ireland, including all the World’s Top 10 Biopharmaceutical companies.
The biopharmaceutical industry has made a capital investment of approximately $10 billion in new facilities in Ireland, most of which has come in the last 10 years. This represents the biggest wave of investment in new biotech facilities anywhere in the world.
Speak with us and you will soon understand why Ireland has developed Europe’s premier biopharma manufacturing cluster.
Minaris Regenerative Medicine is a global contract development and manufacturing organization (CDMO) for cell and gene therapies. We offer our clients high value clinical and commercial manufacturing services, development solutions, and technologies. We are pioneers in the field with 25 years’ experience providing outstanding quality and reliability. Our facilities in North America, Europe, and Asia allow us to supply life-changing therapies to patients globally.
Repligen is a bioprocessing-focused life sciences company bringing expertise and innovation to our customers since 1981. We are inspiring advances in bioprocessing through the development and commercialization of high-value products and flexible solutions that address critical steps in the production of biologic drugs.
Resilience is a technology-focused manufacturing company dedicated to broadening access to complex medicines. Founded in 2020, the company aims to build a sustainable network of high-tech, end-to-end manufacturing solutions to ensure the medicines of today and tomorrow can be made quickly, safely and at scale. By continuously advancing the science of biopharmaceutical manufacturing and development, Resilience seeks to free its partners to focus on the discoveries that improve patients’ lives.
Sharp is a global leader in pharmaceutical packaging and clinical trial supply services. For 70 years, we’ve provided solutions to pharma and biotech clients from phase I trials through to commercial launch and lifecycle management. With facilities in the United States, United Kingdom, Belgium and the Netherlands and 30+ clinical depots globally, covering every region of the world, we are engineered to deliver.
Through our partnership with Berkshire Sterile Manufacturing we offer specialist isolator-based filling of vials, syringes, cartridges and containers, as well as lyophilization and terminal sterilization.
SK pharmteco is a global contract development and manufacturing organization (CDMO) with production sites, research & development facilities, and analytical laboratories across the U.S., Europe, and Korea. The company partners with biopharmaceutical companies of all sizes to manufacture Active Pharmaceutical Ingredients (API) and intermediates, cell and gene therapy technologies, registered starting materials, and analytical services for the biopharmaceutical industry worldwide. SK pharmteco is a subsidiary of SK Inc. (KRX: 034730) (SK), the strategic investment company for SK Group, South Korea’s second-largest conglomerate.
Swinerton provides commercial construction, construction management, design-build, and self-perform services throughout the United States. Founded in 1888, Swinerton is 100% employee-owned and is the preferred builder and trusted partner in every market it serves—proudly leading with ownership, integrity, leadership, passion, and excellence. Swinerton has 22 nationwide offices in Spokane and Seattle, WA; Portland, OR; Boise, ID; Sacramento, Fresno, Concord, San Francisco, Oakland, Santa Clara, Los Angeles, Santa Ana, and San Diego, CA; Honolulu and Maui, HI; Denver, CO; Dallas and Austin, TX; Atlanta, GA; Charlotte and Raleigh, NC; and New York, NY.
At Swinerton, we are committed to turning your vision for cutting-edge life sciences and technology spaces into reality. With expertise in biotech, biomedical, and life sciences sectors, we’re uniquely equipped to deliver advanced, innovative facilities tailored to your needs. Our teams across the nation specialize in various project types, including cleanrooms, R&D facilities, vivarium, and complex laboratories. Whether you’re planning a fast-track tenant improvement or developing a large-scale, ground up campus, Swinerton offers scalable solutions to meet your needs. For more information, please visit swinerton.com.
